Tags:CareDevelopmentDoctorInformationManagementMedicalMedTechPharmacyProductResearchTime
Adolor Corporation (NASDAQ:ADLR) is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The Company's first product, ENTEREG® (alvimopan) was approved by the FDA and launched with Glaxo Group Limited in mid-2008. ENTEREG is indicated to accelerate the time to upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. For more information on ENTEREG, including its full prescribing information, visit www.ENTEREG.com. The Company’s research and development pipeline includes: two novel delta opioid receptor agonists, currently in mid-stage clinical development in collaboration with Pfizer Inc. for chronic pain; a peripheral mu opioid receptor antagonist entering development for chronic opioid bowel dysfunction (OBD); and several opioid and non-opioid discovery programs. Adolor is: -Committed to innovation, focused on invention -Driven by imagination to meet unmet medical needs in pain management
Phone: +234 704 387 4318
Founded date: 1993

Investors 2

Mentions in press and media 11

DateTitleDescriptionCategoryAuthorSource
20.01.2014The 4 Winn...In three days, 15 startups eme...Stories F...-bizjournal...
25.02.2013Cubist Ann... Lexington, Mass., and San ...--domainvc.c...
04.12.2012New broad-...The drug has been tested in mo...--medcitynew...
24.10.2011Cubist Pha...Cubist Pharmaceuticals (NASDAQ...--medcitynew...
23.05.2008Lies, Damn...Share Share on Facebook Share ...-Gregory T....xconomy.co...
26.12.2007Life scien...Romark Labs raises $18M for he...--venturebea...
22.10.2007All Sorts ...Share Share on Facebook Share ...-Rebecca Za...xconomy.co...
16.10.2007Cubist Tak...Share Share on Facebook Share ...-Rebecca Za...xconomy.co...
14.05.2007Antibiotic...Targanta Therapeutics, a Cambr...--venturebea...
-Cubist Pha...Cubist Pharmaceuticals (NASDAQ...--medcitynew...
Show more